Delta 9 Cannabis Stock Net Asset
| DLTNFDelisted Stock | USD 0.01 0.00 0.00% |
Fundamental analysis of Delta 9 allows traders to better anticipate movements in Delta 9's stock price by examining its financial health and performance throughout various phases of its business cycle.
Delta |
Delta 9 Cannabis Company Net Asset Analysis
Delta 9's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Delta 9 Net Asset | 74.78 M |
Most of Delta 9's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Delta 9 Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Delta 9 Cannabis has a Net Asset of 74.78 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.
Delta Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delta 9's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Delta 9 could also be used in its relative valuation, which is a method of valuing Delta 9 by comparing valuation metrics of similar companies.Delta 9 is currently under evaluation in net asset category among its peers.
Delta Fundamentals
| Return On Equity | -0.91 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (0.33) % | |||
| Operating Margin | (0.25) % | |||
| Current Valuation | 54.59 M | |||
| Shares Outstanding | 149.01 M | |||
| Shares Owned By Insiders | 37.09 % | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 0.13 X | |||
| Revenue | 62.29 M | |||
| Gross Profit | 17.32 M | |||
| EBITDA | (1.17 M) | |||
| Net Income | (11.18 M) | |||
| Cash And Equivalents | 13.49 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 2.48 M | |||
| Debt To Equity | 3.50 % | |||
| Current Ratio | 1.41 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (775.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Number Of Employees | 210 | |||
| Beta | 1.09 | |||
| Market Capitalization | 8.48 M | |||
| Total Asset | 74.78 M | |||
| Z Score | 1.8 | |||
| Net Asset | 74.78 M |
About Delta 9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Delta 9 Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delta 9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delta 9 Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| IGIB | iShares 5 10 Year | |
| SPTL | SPDR Barclays Long | |
| SCHH | Schwab REIT ETF | |
| SPMB | SPDR Portfolio Mortgage | |
| SPTI | SPDR Portfolio Intermediate |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Delta Pink Sheet
If you are still planning to invest in Delta 9 Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Delta 9's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |